CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 7,816 shares, a drop of 75.9% from the July 15th total of 32,429 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 78,247 shares, the short-interest ratio is presently 0.1 days.
CochLear Stock Up 0.9%
OTCMKTS CHEOY traded up $0.43 on Thursday, reaching $46.91. The stock had a trading volume of 3,524 shares, compared to its average volume of 57,634. The stock has a fifty day moving average price of $40.92 and a two-hundred day moving average price of $52.68. CochLear has a 12-month low of $31.82 and a 12-month high of $104.65.
Wall Street Analysts Forecast Growth
CHEOY has been the subject of several analyst reports. Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective for the company. in a research report on Thursday, July 16th. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Finally, Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $117.00.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than CochLear
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
- Axos Financial Keeps Proving the Digital Banking Model Works
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
